2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
229
Leukemia, Lymphocytic, Chronic, B-Cell
213
Leukemia
203
Myelodysplastic Syndromes
185
Precursor Cell Lymphoblastic Leukemia-Lymphoma
174
Lymphoma
148
Lymphoma, Non-Hodgkin
142
Multiple Myeloma
131
Hodgkin Disease
123
Lymphoma, Follicular
111
Lymphoma, Mantle-Cell
108
Lymphoma, Large B-Cell, Diffuse
96
Lymphoma, B-Cell, Marginal Zone
89
Myeloproliferative Disorders
86
Congenital Abnormalities
85
Burkitt Lymphoma
85
Leukemia, Myelomonocytic, Chronic
77
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
75
Leukemia, Myeloid, Chronic-Phase
74
Leukemia, Myeloid, Accelerated Phase
73
Recurrence
63
Melanoma
62
Lymphoma, Large-Cell, Immunoblastic
61
Anemia, Refractory, with Excess of Blasts
60
Neoplasms, Plasma Cell
56
Waldenstrom Macroglobulinemia
55
Primary Myelofibrosis
55
Blast Crisis
55
Hematologic Neoplasms
45
Lymphoma, T-Cell, Cutaneous
42
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine phosphate
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled